EQL Pharma AB
EQL SE0005497732
Annual Performance 1
2024 | 2025 |
---|---|
31% | -7% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Magnus Erreth EX OFF |
67.80 SEK |
1,000 Bought |
67,800 SEK |
26/09/2025 | 23/09/2025 |
Alexander Brising EX OFF |
85.57 SEK |
667 Sold |
57,075 SEK |
16/09/2025 | 12/09/2025 |
Axel Schörling CEO |
81.00 SEK |
289,155 Sold |
23,421,555 SEK |
06/09/2025 | 03/09/2025 |
Cornelia Lindström EX OFF |
81.00 SEK |
38,370 Sold |
3,107,970 SEK |
05/09/2025 | 03/09/2025 |
Alexander Brising EX OFF |
81.34 SEK |
10,000 Sold |
813,400 SEK |
22/08/2025 | 21/08/2025 |
Alexander Brising EX OFF |
84.08 SEK |
5,528 Sold |
464,794 SEK |
21/08/2025 | 20/08/2025 |
Alexander Brising EX OFF |
86.07 SEK |
2,054 Sold |
176,788 SEK |
21/08/2025 | 19/08/2025 |
Alexander Brising EX OFF |
86.24 SEK |
7,402 Sold |
638,348 SEK |
21/08/2025 | 18/08/2025 |
Christer Fåhraeus CB |
84.84 SEK |
3,129 Bought |
265,464 SEK |
18/08/2025 | 14/08/2025 |
Chenjie Xu DIR |
87.00 SEK |
2,300 Bought |
200,091 SEK |
11/07/2025 | 08/07/2025 |